TiliaHealth

Private

ViennaHealthcare & Life Scienceshttps://tiliah.com/

Last Round

Grant

Oct 1, 2024

Est. Valuation

$11,000

Total Funding Raised

$11,000

Company Overview

TiliaHealth is a digital health company that develops a platform for gamified assessment of symptoms of mental health disorders to enable mechanism-based diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Clinical Trials, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

digital biomarkersprecision psychiatryclinical outcome assessmentCOAgamified assessmentcomputational psychiatrymental health techdigital phenotypingbehavioral trackingpatient stratificationCNS drug developmentdigital health platformmental health appclinical research toolshealth SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TiliaHealth Comps

Public and private peers based on sector, stage, and business model.

TiliaHealth comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TiliaHealth Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 1, 2024
Pre Seed	May 15, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Walter Sereinig

Chief Technology Officer

Executive Team

TiliaHealth Investors

Notable investors and investment history

TiliaHealth investors
Investor	Rounds
University of Innsbruck	Grant
FFG Austrian Research Promotion Agency	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 11, 2024
Grew 300% QoQ from 1 to 4 employees.
Oct 1, 2024
Received grant funding from FFG Austrian Research Promotion Agency and University of Innsbruck.

View all signals

TiliaHealth Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

TiliaHealth Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TiliaHealth's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna

Employee Range12

Year Founded2024

Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.